ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ITF Therapeutics
A Medical Director at ITF Therapeutics focuses on leading DMD initiatives in the U.S., aligning with global strategy, providing expert guidance to internal and external stakeholders, and managing key medical activities such as advisory boards and field materials.
Headquarters
Concord, Massachusetts, United States
Company Size
1-10 employees
Founded
2024
ITF Therapeutics LLC is a division of Italfarmaco S.p.A., based in the United States and focused on bringing proven treatments to people living with rare diseases. The company commercializes DUVYZAT (givinostat), an FDA-approved HDAC inhibitor for Duchenne muscular dystrophy (DMD), in the U.S. market. ITF Therapeutics combines patient advocacy, medical research support, and community engagement to serve rare disease patients, clinicians, and researchers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ITF Therapeutics.
Director, Medical Science Liaison (Northeast US and Canada)
allogene
Senior Scientific Director, Medical Affairs
Definium Therapeutics
Scientific Affairs Manager
Rhythm Pharmaceuticals
Senior Medical Science Liaison (Central) - Rare Disease
Zevra
Associate Medical Director, Rare Disease - Friedreichs Ataxia (US Medical Affairs)
biogen
Scientific Director, Medical Information & Medical Communications
Tango Therapeutics